Pantoprazole is a proton pump inhibitor that suppresses gastric acid secretion by irreversibly blocking the H+/K+-ATPase enzyme in gastric parietal cells. This medication is clinically indicated for the… Read more
Pantoprazole is a proton pump inhibitor that suppresses gastric acid secretion by irreversibly blocking the H+/K+-ATPase enzyme in gastric parietal cells. This medication is clinically indicated for the management of conditions such as gastroesophageal reflux disease, erosive esophagitis, and Zollinger-Ellison syndrome. This category features a comprehensive range of reference standards, including impurities, metabolites, and stable isotope-labelled compounds, which are essential for pharmaceutical research and quality control. Laboratories utilize these materials for impurity profiling, method development, and validation to ensure compliance with stringent regulatory standards and ICH guidelines. By facilitating the accurate identification and quantification of process-related impurities, synthetic intermediates, and degradation products, these reference materials support the rigorous analytical testing required to maintain therapeutic efficacy and patient safety throughout the manufacturing and stability assessment processes of this proton pump inhibitor.